Nick Galifianakis, MPH, MD

Neurologist

Dr. Nicholas Galifianakis is a neurologist who specializes in a comprehensive approach to the treatment of Parkinson's disease, essential tremor, dystonia and other movement disorders. Treatments include deep brain stimulation (DBS), botulinum toxin injections and medications. His research interests include clinical outcomes in deep brain stimulation for Parkinson's disease and essential tremor, such as the use of new interventional MRI techniques. He also is interested in defining types of essential tremor and developing more complete models of care for advanced Parkinson's disease.

Galifianakis earned a medical degree and completed a neurology residency at the University of Southern California (USC) in Los Angeles, where he served as chief-resident. He completed a movement disorders fellowship at the University of Pennsylvania and UCSF. Galifianakis is an associate professor of neurology in the UCSF School of Medicine. He also sees patients at the Parkinson's Disease Research, Education and Clinical Center (PADRECC), a Veterans Affairs center of excellence. He is a member of the American Academy of Neurology and the Movement Disorders Society.

Clinics

Movement Disorder and Neuromodulation Center
1635 Divisadero St., Suite 520
San Francisco, CA 94115
Neurology: (415) 353-2311
Neurosurgery: (415) 353-2071
Fax: (415) 353-9060

Hours: Monday to Friday
8 a.m. – 5 p.m.

Conditions & Treatments

Board Certification

Neurology, American Board of Psychiatry and Neurology

Academic Title

Associate Professor

More about Nick Galifianakis

Education

University of Southern California (USC) 2003

Residencies

USC Medical Center, Neurology 2007

Fellowships

University of Pennsylvania Medical Center, Neurology 2008

Selected Research and Publications

  1. Wang DD, de Hemptinne C, Miocinovic S, Ostrem JL, Galifianakis NB, San Luciano M, Starr PA. Pallidal Deep-Brain Stimulation Disrupts Pallidal Beta Oscillations and Coherence with Primary Motor Cortex in Parkinson's Disease. J Neurosci. 2018 May 09; 38(19):4556-4568.
  2. Hassan A, Dorsey ER, Goetz CG, Bloem BR, Guttman M, Tanner CM, Mari Z, Pantelyat A, Galifianakis NB, Bajwa JA, Gatto EM, Cubo E. Telemedicine Use for Movement Disorders: A Global Survey. Telemed J E Health. 2018 Mar 22.
  3. Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, Simone R, Willis AW, Galifianakis NB, Katz M, Tanner CM, Dodenhoff K, Aldred J, Carter J, Fraser A, Jimenez-Shahed J, Hunter C, Spindler M, Reichwein S, Mari Z, Dunlop B, Morgan JC, McLane D, Hickey P, Gauger L, Richard IH, Mejia NI, Bwala G, Nance M, Shih LC, Singer C, Vargas-Parra S, Zadikoff C, Okon N, Feigin A, Ayan J, Vaughan C, Pahwa R, Dhall R, Hassan A, DeMello S, Riggare SS, Wicks P, Achey MA, Elson MJ, Goldenthal S, Keenan HT, Korn R, Schwarz H, Sharma S, Stevenson EA, Zhu W. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017 Sep 12; 89(11):1152-1161.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.